Does dose reduction of afatinib affect treatment outcomes of patients with EGFR-mutant metastatic non-small cell lung cancer in real-world clinical practice?

by Mau, Ern Poh, Chai, Chee Shee, Chong, Kin Liam, Go, Fuang Ho, Yong, Kek Pang, Harissa, Husainy Hasbullah, Lye, Mun Tho, Ibtisam, Muhamad Nor, Kean, Fatt Ho, Muthukkumaran, Thiagarajan, Azlina, Samsudin, Azza, Omar, Choo, Khoon Ong, Sing, Yang Soon, Sin, Nee Tan, Soon, Hin How
Published 2024